Biowarfare Through the Food Supply

In an April 17, 2023, opinion piece in STAT News,¹ Dr. Peter Lurie and Beth Ellikidis argue for the genetic engineering of food, claiming “newer technologies can make highly targeted changes at the base-pair level — one specific rung on the DNA ladder — enhancing precision and reducing the likelihood of ‘off-target effects’ in which the base pairs are unintentionally added to or deleted from the genome.”

While targeted genetic engineering is indeed possible, and modern technology lowers the likelihood of unintentional additions or deletions, this precision does not guarantee there won’t be adverse effects. One of the reasons for this is because many genes are multifunctional and can have multiple downstream effects.^2,3

By altering a single gene, you can inadvertently affect the expression of hundreds of others. What’s more, the multifunctionality of genes is rarely intuitive. So, while it may seem convenient to genetically engineer cows without horns to prevent injury to other cows and farmhands, as suggested by Lurie and Ellikidis, there’s no telling what that tweak might do to internal organs or biological pathways.

In turn, there’s no guarantee that cascading effects will not alter the nutrition of the meat or dairy that comes from that cow. Maybe it’ll be fine, maybe it won’t. The problem is that, oftentimes with genetically engineered foods, safety testing is minimal or absent.

Who Do Lurie and Ellikidis Answer To?

When assessing the trustworthiness of people, it can be worthwhile to look at their funding and various partnerships. In the case of Lurie and Ellikidis, both are in league with Bill Gates and other Great Resetters that are pushing to replace all natural foods with patentable, genetically modified foods.

Lurie — a former FDA associate commissioner — is the president of the Center for Science in the Public Interest (CSPI). In the summer of 2020, Lurie launched a comprehensive campaign to put Mercola.com out of business by sending the U.S. Food and Drug Administration and the Federal Trade Commission after us based on bogus charges.

CSPI is funded by the Rockefeller Foundation, the Rockefeller Family Fund, Bloomberg Philanthropies and other billionaire-owned foundations. It’s also partnered with the Cornell Alliance for Science, a “global communications initiative” whose primary funding comes from the Bill & Melinda Gates Foundation. Greg Jaffe, who heads up CSPI’s Biotechnology Project, is also the associate director of legal affairs at Alliance for Science.

Considering those ties, the CSPI’s long history of promoting industry science and propaganda is not surprising in the least. They supported artificial sweeteners, trans fats, GMOs, fake meat and the low-fat myth. They’ve also actively undermined transparency in labeling efforts.

Ellikidis, meanwhile, is the vice president of agriculture and environment at the Biotechnology Innovation Organization (BIO). She’s leading the “policy and market access strategies for BIO’s Agriculture and Environment section, which includes member companies developing and producing breakthrough technologies in food and agriculture.”⁴

BIO, the world’s largest GMO trade organization,^5,6 represents more than 1,000 pesticide, pharmaceutical and biotech companies in more than 30 countries, as well as industry groups, academic institutions, state biotechnology centers and other related organizations.

According to BIO, genetic engineering is the solution to heal, fuel and feed the world, and to that end, it has lobbying committees dedicated to influencing 15 different policy areas, including food, agriculture, health care policy, technology transfer and finance.

According to Open Secrets,⁷ BIO spent $13,250,000 on “pharmaceutical and health products” lobbying in 2022. For reference, only Pfizer and the lobbying group Pharmaceutical Research and Manufacturers of America spent more.⁸

How Gates Sets Himself Up for Success

In 2004, BIO launched BIO Ventures for Global Health (BVGH),⁹ a nonprofit organization that “strategically develops and manages programs across the for-profit and non-profit sectors to accelerate research and development (R&D) for poverty-related diseases.”

BVGH was launched with a $1 million start-up grant from the Bill & Melinda Gates Foundation.¹⁰ In 2005, the BVGH received another $5.4 million to expand the biotech industry’s role in the fight against neglected diseases.¹¹ The Rockefeller Foundation is also funding the group.

Fast-forward to 2018, and the Bill & Melinda Gates Foundation spun off a nonprofit subsidiary to the foundation called the Bill & Melinda Gates Medical Research Institute (Gates MRI).¹² Gates MRI, funded with a $273 million, four-year grant from the Gates Foundation, is focused on developing biotechnologies to address health problems in poor countries.¹³

It’s a convenient setup to say the least. On the one hand, Gates is funding the R&D of biotech products through Gates MRI, and on the other, he’s funding the acceleration, coordination and management of private-public biotech programs through BVGH.

One key area where the BVGH is being inserted to manage private-public programs is the “Cancer Moonshot” program, launched in 2016 by then-Vice President Joe Biden. Biden “reignited” and highlighted the program in 2022.¹⁴ As reported in a White House fact sheet:¹⁵

“Working with African Access Initiative (AAI) partners, BIO Ventures for Global Health (BVGH) will implement cancer research projects that are determined and led by African oncologists and conducted in collaboration with U.S. cancer experts.

Through its African Consortium for Cancer Clinical Trials (AC³T) program, BVGH will facilitate five research projects, build capacity to conduct rigorous clinical research at 50 African sites, promote African primary investigator’s research interests on the AC³T platform, and coordinate the implementation of observational clinical studies.

In addition to building AC³T sites’ research capacity, BVGH will map the regulatory pathway in five AAI countries. All clinical studies involving cancer drugs will include development of market access pathways by BVGH.”

Gates MRI, in turn, intends to “apply new understanding of the human immune system learned from cancer research to prevent infectious disease.”¹⁶ Conveniently, he’s got the inside track to all of that through the BVGH.